Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase One, Open Label Assessment of a Dengue-3-Virus-Live Virus Human Challenge - (DENV-3-LVHC) Virus Strain

NCT04298138 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT04298138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04298138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase One, Open Label Assessment of a Dengue-3-Virus-Live Virus Human Challenge - (DENV-3-LVHC) Virus Strain
Lead sponsor
State University of New York - Upstate Medical University
Phase
Phase 1
Overall status
Completed
Start date
August 3, 2020
Completion date
December 14, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue